chevron_leftBack
As of 15 June 2026, Yifan Pharmaceutical Co., Ltd. has a market cap of $1.72B USD, ranking #7762 globally and #1959 in China.
It ranks #642 in the Healthcare sector, and #247 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.72BUSD
11.65B CNY
Enterprise Value
$1.94BUSD
13.14B CNY
Revenue (TTM)
$747.97MUSD
5.06B CNY
EBITDA (TTM)
$110.03MUSD
744.64M CNY
Net Income (TTM)
$52.56MUSD
355.69M CNY
EBITDA Margin
15%
Profit Margin
7%
PE Ratio
38.5
PS Ratio
2.3
PB Ratio
1.3
EV/EBITDA
17.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Xian Feng Cheng
open_in_new
Employees
4,098
Founded
2000
Website
yifanyy.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.5% | -4.9% | -15% | -9.3% | -15% | -4.4% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002019
亿帆医药股份有限公司 Class A
ISIN: CNE000001K65
Shares Out.:
Shares Outstanding:
1.216B1
Shares Float:
1.004B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
11.18 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Yifan Pharmaceutical Co., Ltd.
Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 and original B5. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is headquartered in Hangzhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.92B
3K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.7B
3K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
2K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
992%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.53B
860%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
830%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
44K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
32K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
21K%
|
97.4
|
|
SIX: RO
|
$321.52B
19K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
17K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
16K%
218.9B CHF
|
20.5
|
chevron_leftBack